Fifty years ago, the American Association of Neurological Surgeons (AANS) and Congress of Neurological Surgeons (CNS) recognized the growing impact of federal policy on medicine and took bold action: they established the AANS/CNS Washington Committee for Neurological Surgery. This formal presence in the nation’s capital has since served as the unified voice of neurosurgery in Congress and within federal agencies.
“Throughout its history, the Washington Committee has been critical to CNS’ mission of enhancing health and improving lives. We are grateful to our Washington Committee representatives for their tireless efforts to ensure healthcare policies are patient-centered and address the needs of both patients and neurosurgeons,” states Regina Shupak, CNS CEO. Since its inception in 1975, the Washington Committee has worked to advance neurosurgery, influence policy decisions, and advocate for patient access to high-quality neurosurgical care.
Over the decades, the Washington Committee broadened its focus to address the full range of federal policies impacting neurosurgical practice and patient care — from reimbursement and medical liability reform to quality reporting, research funding, and access to innovative technologies. This strategic expansion has ensured that neurosurgery remains at the table and it has also achieved meaningful policy victories.
To keep pace with a rapidly evolving policy landscape, the Washington Committee expanded its structure, establishing subcommittees led by neurosurgeon volunteers that focus on key areas such as coding and reimbursement, clinical guidelines, medical device regulation, public communications, and quality improvement. It also includes delegates to the American Medical Association to maintain influence in organized medicine. Supporting this work has grown from a single staff member to a team of five, complemented by experienced consultants and targeted coalitions that the Committee has established and supports to advance key advocacy priorities.
“The Washington Committee has been at the forefront of major health care policy issues for 50 years, successfully advocating for fair reimbursement, reducing regulatory burdens, and securing funding for critical neurosurgical research and training. Through its steadfast dedication and strategic advocacy, the AANS and the CNS have preserved access to life-saving neurosurgical care for patients while ensuring neurosurgeons can continue to innovate and lead in an evolving health care landscape,” states Katie O. Orrico, JD, AANS CEO.
“The Washington Committee’s accomplishments over the past five decades highlight the incredible dedication of our neurosurgeons — both in the operating room and in the halls of Congress — and it has been an honor to play a small role in helping advance sound health policy. As we look to the next 50 years, the work of the Washington Committee is more critical than ever to help neurosurgery navigate complex policy challenges and drive meaningful legislative and regulatory change to preserve the specialty for generations of neurosurgeons and patients to come,” Ms. Orrico added.
The Washington Committee remains committed to advancing policies that support neurosurgical excellence, scientific innovation, and equitable patient access. Its legacy of impact reflects the strength of neurosurgery’s collective voice — and its future depends on continued engagement from the neurosurgical community.
Editor’s Note: This article originally appeared in the Spring 2025 CNS Congress Quarterly. We hope you will share what you learn from our posts. We invite you to join the conversation on X by following @Neurosurgery, @AANSNeuro, and @CNS_Update.





From time to time on Neurosurgery Blog, you will see us cross-posting or linking to items from other sources that we believe are relevant to our audience. Since this week featured International Women’s Day, we wanted to bring your attention to the March 2021 Neurosurgical Focus issue on
emerging roles of women as leaders in international organizations. Various aspects of research are described, including funding gaps and publication rates.



Sepideh Amin-Hanjani, MD, FAANS, and coauthors representing multiple academic institutions 

